Clal Biotechnology Industries Ltd

XTAE:CBI (Israel)  
₪ 0.44 (+1.14%) May 30
At Loss
P/B:
0.71
Market Cap:
₪ 69.33M ($ 18.64M)
Enterprise V:
₪ 91.73M ($ 24.66M)
Volume:
52.02K
Avg Vol (2M):
88.95K
Also Trade In:
Volume:
52.02K
At Loss
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Clal Biotechnology Industries Ltd ( ) from 2007 to May 31 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Clal Biotechnology Industries stock (XTAE:CBI) PE ratio as of May 31 2024 is 0. More Details

Clal Biotechnology Industries Ltd (XTAE:CBI) PE Ratio (TTM) Chart

To

Clal Biotechnology Industries Ltd (XTAE:CBI) PE Ratio (TTM) Historical Data

Total 1244
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Clal Biotechnology Industries PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-31 At Loss 2024-03-28 At Loss
2024-05-30 At Loss 2024-03-27 At Loss
2024-05-29 At Loss 2024-03-26 At Loss
2024-05-28 At Loss 2024-03-25 At Loss
2024-05-27 At Loss 2024-03-24 At Loss
2024-05-26 At Loss 2024-03-21 At Loss
2024-05-23 At Loss 2024-03-20 At Loss
2024-05-22 At Loss 2024-03-19 At Loss
2024-05-21 At Loss 2024-03-18 At Loss
2024-05-20 At Loss 2024-03-17 At Loss
2024-05-19 At Loss 2024-03-14 At Loss
2024-05-16 At Loss 2024-03-13 At Loss
2024-05-15 At Loss 2024-03-12 At Loss
2024-05-14 At Loss 2024-03-11 At Loss
2024-05-13 At Loss 2024-03-10 At Loss
2024-05-12 At Loss 2024-03-07 At Loss
2024-05-09 At Loss 2024-03-06 At Loss
2024-05-08 At Loss 2024-03-05 At Loss
2024-05-07 At Loss 2024-03-04 At Loss
2024-05-06 At Loss 2024-03-03 At Loss
2024-05-05 At Loss 2024-02-29 At Loss
2024-05-02 At Loss 2024-02-28 At Loss
2024-05-01 At Loss 2024-02-27 At Loss
2024-04-30 At Loss 2024-02-26 At Loss
2024-04-29 At Loss 2024-02-25 At Loss
2024-04-28 At Loss 2024-02-22 At Loss
2024-04-25 At Loss 2024-02-21 At Loss
2024-04-24 At Loss 2024-02-20 At Loss
2024-04-23 At Loss 2024-02-19 At Loss
2024-04-22 At Loss 2024-02-18 At Loss
2024-04-21 At Loss 2024-02-15 At Loss
2024-04-18 At Loss 2024-02-14 At Loss
2024-04-17 At Loss 2024-02-13 At Loss
2024-04-16 At Loss 2024-02-12 At Loss
2024-04-15 At Loss 2024-02-11 At Loss
2024-04-14 At Loss 2024-02-08 At Loss
2024-04-11 At Loss 2024-02-07 At Loss
2024-04-10 At Loss 2024-02-06 At Loss
2024-04-09 At Loss 2024-02-05 At Loss
2024-04-08 At Loss 2024-02-04 At Loss
2024-04-04 At Loss 2024-02-01 At Loss
2024-04-03 At Loss 2024-01-31 At Loss
2024-04-02 At Loss 2024-01-30 At Loss
2024-04-01 At Loss 2024-01-29 At Loss
2024-03-31 At Loss 2024-01-28 At Loss

Clal Biotechnology Industries Ltd (XTAE:CBI) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.